362 related articles for article (PubMed ID: 34498777)
1. Can direct oral anticoagulants be used in kidney transplant recipients?
Parker K; Chu J; Morton M; Bhutani S; Picton M; Mitra S; Thachil J
Clin Transplant; 2021 Dec; 35(12):e14474. PubMed ID: 34498777
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Direct Oral Anticoagulants in Kidney Transplantation: A Single-center Pilot Experience.
Leon J; Sabbah L; Aubert O; Anglicheau D; Delavenne X; Zuber J; Amrouche L; Scemla A; Giura G; Divard G; Legendre C; Sberro-Soussan R
Transplantation; 2020 Dec; 104(12):2625-2631. PubMed ID: 32044892
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis.
Sharma M; Cornelius VR; Patel JP; Davies JG; Molokhia M
Circulation; 2015 Jul; 132(3):194-204. PubMed ID: 25995317
[TBL] [Abstract][Full Text] [Related]
4. Characterization of direct oral anticoagulants use in adult hematopoietic stem cell transplant recipients.
Yang C; Khan F; MacDonald C; Guglielmo J; Lo M; Young R; Banez MT; Huang L; Nguyen R; Kang S; Saunders IM
J Thromb Thrombolysis; 2024 Feb; 57(2):293-301. PubMed ID: 37932590
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.
Shah S; Norby FL; Datta YH; Lutsey PL; MacLehose RF; Chen LY; Alonso A
Blood Adv; 2018 Feb; 2(3):200-209. PubMed ID: 29378726
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation prescribing patterns in patients with cancer.
Xiang E; Ahuja T; Raco V; Cirrone F; Green D; Papadopoulos J
J Thromb Thrombolysis; 2018 Jan; 45(1):89-98. PubMed ID: 29052104
[TBL] [Abstract][Full Text] [Related]
7. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants].
Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T
Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024
[TBL] [Abstract][Full Text] [Related]
9. Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia.
Shovlin CL; Millar CM; Droege F; Kjeldsen A; Manfredi G; Suppressa P; Ugolini S; Coote N; Fialla AD; Geisthoff U; Lenato GM; Mager HJ; Pagella F; Post MC; Sabbà C; Sure U; Torring PM; Dupuis-Girod S; Buscarini E;
Orphanet J Rare Dis; 2019 Aug; 14(1):210. PubMed ID: 31462308
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: Direct oral anticoagulants versus vitamin-k antagonists.
Santoro F; Casanova A; Simone S; Alfieri C; Falcone A; Dello Strologo A; Grandinetti V; Busutti M; Comai G; Marvulli TM; Zippo MG; Castellano G; La Manna G; Gesualdo L; Giuseppe G; Pesce F
Eur J Intern Med; 2024 Jan; 119():71-77. PubMed ID: 37573220
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Safety and Efficacy of Direct Oral Anticoagulants and Warfarin in Atrial Fibrillation or Venous Thromboembolism in Patients with Renal Impairment: Systematic Review, Meta-Analysis and Network Meta-Analysis.
Wang Z; Xiang Q; Hu K; Zhang X; Xie Q; Liu Z; Cui Y
Am J Cardiovasc Drugs; 2021 Nov; 21(6):643-657. PubMed ID: 33817758
[TBL] [Abstract][Full Text] [Related]
12. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.
Djulbegovic M; Lee AI; Chen K
J Eval Clin Pract; 2020 Feb; 26(1):7-17. PubMed ID: 31190408
[TBL] [Abstract][Full Text] [Related]
13. Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication.
Schaefer JK; Errickson J; Li Y; Kong X; Alexandris-Souphis T; Ali MA; Decamillo D; Haymart B; Kaatz S; Kline-Rogers E; Kozlowski JH; Krol GD; Shankar SR; Sood SL; Froehlich JB; Barnes GD
JAMA Intern Med; 2021 Jun; 181(6):817-824. PubMed ID: 33871544
[TBL] [Abstract][Full Text] [Related]
14. A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease.
Starr JA; Pinner NA; Mannis M; Stuart MK
Ann Pharmacother; 2022 Jun; 56(6):691-703. PubMed ID: 34459281
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients.
Lutsey PL; Norby FL; Zakai NA; MacLehose RF; Chen LY; Shah S; Datta YH; Alonso A
Curr Med Res Opin; 2019 May; 35(5):837-845. PubMed ID: 30362847
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Direct Oral Anticoagulation Therapy in Heart and Lung Transplant Recipients.
Lichvar AB; Moore CA; Ensor CR; McDyer JF; Teuteberg JJ; Shullo MA
Prog Transplant; 2016 Sep; 26(3):263-9. PubMed ID: 27597772
[TBL] [Abstract][Full Text] [Related]
18. Direct oral anticoagulants in patients with cancer.
Bossaer JB; Covert KL
Am J Health Syst Pharm; 2019 Jul; 76(14):1019-1027. PubMed ID: 31361880
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants.
Ay C; Beyer-Westendorf J; Pabinger I
Ann Oncol; 2019 Jun; 30(6):897-907. PubMed ID: 30918939
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.
Russo V; Cattaneo D; Giannetti L; Bottino R; Laezza N; Atripaldi U; Clementi E
Clin Ther; 2021 Sep; 43(9):e255-e263. PubMed ID: 34366151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
